Profit Expected to Dip for Teva Pharmaceutical Industries
Despite an expected dip in profit, analysts are generally optimistic about Teva Pharmaceutical Industries as it prepares to reports its third-quarter earnings on Thursday, October 30, 2014. The consensus earnings per share estimate is $1.23 per share.
Teva Pharmaceutical Industries Ltd Given Neutral Rating at Zacks (TEVA)Mideast Time
all 2 news articles >>
Source: pharmaceutical – Google News
Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd